Sustained Clearance of Superficial Basal Cell Carcinomas Treated With Imiquimod Cream 5%: Results of a Prospective 5-Year Study

Article Type
Article
Changed
Thu, 01/10/2019 - 12:20
Display Headline
Sustained Clearance of Superficial Basal Cell Carcinomas Treated With Imiquimod Cream 5%: Results of a Prospective 5-Year Study
Author(s)
Quirk C
Gebauer K
De'ambrosis B
Slade HB
Meng T-C

Article PDF
085060318.pdf
Author and Disclosure Information

Quirk C, Gebauer K, De'Ambrosis B, Slade HB, Meng T-C

Issue
Cutis - 85(6)
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Page Number
318-324
Sections
Original Research
Author(s)
Quirk C
Gebauer K
De'ambrosis B
Slade HB
Meng T-C
Author(s)
Quirk C
Gebauer K
De'ambrosis B
Slade HB
Meng T-C
Author and Disclosure Information

Quirk C, Gebauer K, De'Ambrosis B, Slade HB, Meng T-C

Author and Disclosure Information

Quirk C, Gebauer K, De'Ambrosis B, Slade HB, Meng T-C

Article PDF
085060318.pdf
Article PDF
085060318.pdf

Issue
Cutis - 85(6)
Issue
Cutis - 85(6)
Page Number
318-324
Page Number
318-324
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Article Type
Article
Display Headline
Sustained Clearance of Superficial Basal Cell Carcinomas Treated With Imiquimod Cream 5%: Results of a Prospective 5-Year Study
Display Headline
Sustained Clearance of Superficial Basal Cell Carcinomas Treated With Imiquimod Cream 5%: Results of a Prospective 5-Year Study
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Meng T-C